snyderman nancy lynn MD — SEC Form 4 filings
SEC reporting owner CIK 1675198. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-03.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-04 to 2026-08-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 44,472 shares, $2,239,076 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 36.
- Largest priced transaction: sale of 44,472 shares @ $50.35 ($2,239,076) in Alkermes plc., filed 2026-08-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Alkermes plc. (ALKS) | Director | 6 | — | 1 leg · 44,472 sh · $2,239,076 | 30 |
| Axonics, Inc. (AXNX) | Director | 2 | — | — | 4 |
| Lyra Therapeutics, Inc. (LYRA) | Director | 2 | — | — | 2 |
Form 4 filings — snyderman nancy lynn MD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-03 | 4 | Alkermes plc. (ALKS) | Option exercise (M): 27,948 @ $46.72 · Option exercise (M): 16,524 @ $46.72 · Sale (S): 44,472 @ $50.35 · Option exercise (M): 27,948 (derivative) @ $0 · Option exercise (M): 16,524 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Alkermes plc. (ALKS) | Option exercise (M): 6,142 · Tax withholding (F): 1,475 @ $36.95 · Grant/award (A): 11,538 (derivative) @ $0 · Grant/award (A): 5,409 (derivative) @ $0 · Option exercise (M): 6,142 (derivative) | EDGAR |
| 2025-06-02 | 4 | Alkermes plc. (ALKS) | Option exercise (M): 8,013 · Tax withholding (F): 1,924 @ $30.61 · Option exercise (M): 8,013 (derivative) | EDGAR |
| 2025-05-23 | 4 | Alkermes plc. (ALKS) | Grant/award (A): 13,474 (derivative) @ $0 · Grant/award (A): 6,142 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2024-11-15 | 4 | Axonics, Inc. (AXNX) | Disposition to issuer (D): 14,944 @ $71 · Disposition to issuer (D): 4,167 (derivative) @ $36.90 · Disposition to issuer (D): 10,000 (derivative) @ $49.96 | EDGAR |
| 2024-11-12 | 4 | Axonics, Inc. (AXNX) | Gift (G): 5,000 @ $0 | EDGAR |
| 2024-07-01 | 4 | Alkermes plc. (ALKS) | Option exercise (M): 6,104 · Tax withholding (F): 1,465 @ $24.10 · Option exercise (M): 6,104 (derivative) | EDGAR |
| 2024-06-14 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Alkermes plc. (ALKS) | Other (J): 548 (derivative) @ $46.72 · Other (J): 324 (derivative) @ $46.72 · Other (J): 284 (derivative) @ $57.11 · Other (J): 350 (derivative) @ $44.75 · Other (J): 448 (derivative) @ $24.55 · Other (J): 256 (derivative) @ $16.52 · +7 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1675198 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →